GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
-$4.36M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$9.27M
2
+$8.22M
3
+$5.07M
4
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$4.49M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$3.59M

Top Sells

1
+$27.3M
2
+$14.3M
3
+$14.2M
4
MDCO
Medicines Co
MDCO
+$5.69M
5
STML
Stemline Therapeutics, Inc.
STML
+$4.2M

Sector Composition

1 Healthcare 60.74%
2 Technology 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$40.7M 17.08%
1,437,335
+327,335
2
$23.6M 9.92%
569,658
-657,127
3
$20.9M 8.75%
1,414,927
+52,164
4
$19.6M 8.2%
2,100,101
+385,101
5
$19.5M 8.17%
97,000
+41,000
6
$14.9M 6.25%
4,127,232
7
$12.6M 5.3%
287,517
+115,348
8
$11.5M 4.81%
2,032,494
+442,494
9
$8.77M 3.68%
1,546,888
+411,308
10
$7.4M 3.11%
39,286
+23,810
11
$6.74M 2.83%
355,459
-98,419
12
$6.67M 2.8%
1,282,527
-52,473
13
$6.16M 2.59%
2,457,144
14
$6.13M 2.57%
1,963,777
15
$5.63M 2.36%
2,680,000
16
$5.38M 2.26%
2,086,028
17
$3.98M 1.67%
1,002,962
18
$3.64M 1.53%
35
19
$2.43M 1.02%
14,992
20
$1.65M 0.69%
856,602
+409,576
21
$214K 0.09%
10,107
22
– –
0
23
– –
0
24
– –
-5,000
25
– –
-112,211
1
2